MRVI Insider Trading Activity and SEC Form 4 Filings
MRVI insider trading summary
Over the past 12 months, insiders at Maravai Lifesciences Holdings, Inc. (MRVI) reported 5 open-market purchases worth $1.9M by 2 insiders and 2 sales worth $254K by 1 insider on SEC Form 4. Net insider buying was $1.6M.
Latest MRVI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Kurt Oreshack | General Counsel | Sell | $127K (25,000 @ $5.10) |
| Jun 9, 2026 | Kurt Oreshack | General Counsel | Sell | $126K (25,000 @ $5.06) |
| Dec 8, 2025 | Gregory T Lucier | Director | Buy | $178K (48,528 @ $3.67) |
| Dec 5, 2025 | Gregory T Lucier | Director | Buy | $190K (51,472 @ $3.70) |
| Nov 13, 2025 | Bernd Brust | Chief Executive Officer | Buy | $703K (216,212 @ $3.25) |
| Nov 12, 2025 | Bernd Brust | Chief Executive Officer | Buy | $300K (93,358 @ $3.21) |
| Nov 11, 2025 | Bernd Brust | Chief Executive Officer | Buy | $509K (157,201 @ $3.24) |
| Jan 31, 2025 | Kurt Oreshack | General Counsel | Sell | $126K (25,000 @ $5.03) |
| Nov 12, 2024 | John A DeFord | Director | Buy | $101K (17,500 @ $5.75) |
| Nov 11, 2024 | Carl Hull | See Remarks | Buy | $987K (175,000 @ $5.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.